TRUALT Share Price | TruAlt Bioenergy Ltd Stock Analysis & Recommendation

Q: Why is TruAlt Bioenergy Ltd falling/rising?

As of 03-Jun, TruAlt Bioenergy Ltd's stock price is currently at 506.50, reflecting a decrease of 1.25 (-0.25%). The stock has underperformed its sector by 1.77% today and has experienced a trend reversal, falling after two consecutive days of gains. This decline is further highlighted by the stock touching an intraday low of Rs 484.55, which represents a significant drop of 4.57%.Despite the recent price drop, the stock has shown positive performance over longer periods, with a 1-week increase of 2.75% and a year-to-date increase of 25.29%. However, the current decline can be attributed to several negative factors. The company has reported a significant profit decrease of 43% over the past year, and its latest six-month profit after tax has grown at a negative rate of 30.86%. Additionally, the company has a high Debt to EBITDA ratio of 5.60 times, indicating a low ability to service its debt, which raises concerns among investors.Moreover, 36.85% of promoter shares are pledged, which can exert additional downward pressure on the stock price in a falling market. The falling investor participation, with a delivery volume decrease of 26.44% against the 5-day average, also suggests waning interest among investors, contributing to the stock's current decline. Overall, while the stock has shown resilience in the past, the combination of weak fundamentals and negative market sentiment is leading to its current price drop.

Q: Are TruAlt Bioenergy Ltd latest results good or bad?

TruAlt Bioenergy Ltd's latest results indicate a challenging financial performance. For Q4 FY26, the company reported a net profit of ₹59.88 crore, which is a significant decline of 46.39% year-on-year. Revenue also fell sharply by 34.34% year-on-year to ₹595.52 crore, although it showed some recovery from a very low figure in the previous quarter.While the operating margin improved slightly to 19.94%, this was overshadowed by the drop in net profit margin, which decreased to 10.23%. The company is grappling with high interest expenses and a substantial debt burden, which raises concerns about its financial stability.Despite these negative indicators, the stock reacted positively to the results, gaining 3.45% on the day of the announcement, as investors seemed to focus on sequential improvements rather than the year-on-year declines. Over the past three months, the stock has performed well, rallying 21.04%, significantly outperforming the broader market.Overall, while there are some signs of recovery in terms of operating margins and stock performance, the underlying financial metrics suggest that TruAlt Bioenergy is facing serious challenges, particularly with revenue volatility and high leverage. Therefore, the latest results can be viewed as concerning rather than good.

Q: Should I buy, sell or hold TruAlt Bioenergy Ltd?

Based on the current situation of TruAlt Bioenergy Ltd, it would be advisable to consider selling your shares. The company is facing several challenges, including high debt levels and weak long-term fundamental strength, despite being net-debt free. The reported losses and negative return on capital employed (ROCE) indicate underlying issues with profitability.Additionally, the recent performance shows a significant decline, with a 30.86% drop in profit after tax over the last six months. The fact that 36.85% of promoter shares are pledged raises concerns, especially in a falling market, as this could exert further downward pressure on the stock price.While there are some positive aspects, such as a fair valuation and a substantial increase in profits over the past year, the overall indicators suggest that holding or buying more shares may not be prudent at this time. Therefore, selling could be the most sensible option given the current circumstances.

Q: When is the next results date for TruAlt Bioenergy Ltd?

The next results date for TruAlt Bioenergy Ltd is scheduled for 22 May 2026.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

21.81 lacs (189.39%) Volume

Shareholding (Mar 2026)

FII

0.66%

Held by 11 FIIs

DII

9.40%

Held by 9 DIIs

Promoter

70.55%

Which are the latest news on TruAlt Bioenergy?

07-Jun-2026

TruAlt Bioenergy Ltd Valuation Shifts to Fair Amidst Strong Market Returns
TruAlt Bioenergy Ltd Hits Intraday Low Amid Price Pressure on 25 May 2026

Why is TruAlt Bioenergy Ltd falling/rising?

04-Jun-2026

As of 03-Jun, TruAlt Bioenergy Ltd's stock price is at 506.50, down 1.25 (-0.25%). The stock has faced a decline due to weak fundamentals, including a 43% profit decrease over the past year and high debt levels, despite showing positive performance over longer periods.

View full answer

Are TruAlt Bioenergy Ltd latest results good or bad?

23-May-2026

TruAlt Bioenergy Ltd's latest results are concerning, showing a 46.39% decline in net profit and a 34.34% drop in revenue year-on-year, despite slight improvements in operating margins. While the stock reacted positively, the company faces significant challenges due to high debt and revenue volatility.

View full answer

Should I buy, sell or hold TruAlt Bioenergy Ltd?

23-May-2026

When is the next results date for TruAlt Bioenergy Ltd?

20-May-2026

The next results date for TruAlt Bioenergy Ltd is 22 May 2026.

View full answer

Compare TruAlt Bioenergy with Similar Stocks

Gujarat Alkalies GHCL India Glycols

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.60 times

Flat results in Mar 26

36.85% of Promoter Shares are Pledged

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Commodity Chemicals

Market cap

INR 4,413 Cr (Small Cap)

P/E

45.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

1.01

Return on Equity

5.29%

Price to Book

2.88

Revenue and Profits:

Net Sales:

596 Cr

(Quarterly Results - Mar 2026)

Net Profit:

60 Cr

Total Returns

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

40.5%

6 Months

30.19%

1 Year

0.0%

2 Years

0.0%

3 Years

0.0%

4 Years

0.0%

5 Years

0.0%

TruAlt Bioenergy for the last several years.

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

TruAlt Bioenergy Ltd is Rated Sell

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

TruAlt Bioenergy Ltd is Rated Sell

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

TruAlt Bioenergy Ltd is Rated Sell

TruAlt Bioenergy Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance

29-May-2026 | Source : BSE

Annual Secretarial Compliance Report for the financial year ended March 31 2026.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

28-May-2026 | Source : BSE

Transcript of earning conference call held on May 22 2026 at 05:00 PM on the audited financial results for the quarter and year ended March 31 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

23-May-2026 | Source : BSE

Newspaper publication for the audited standalone and consolidated financial results for the quarter and year ended March 31 2026.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

1.28

Debt to EBITDA (avg)

5.37

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

0.60

Tax Ratio

26.89%

Dividend Payout Ratio

Pledged Shares

36.85%

Institutional Holding

10.07%

ROCE (avg)

7.70%

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.88

EV to EBIT

29.62

EV to EBITDA

20.82

EV to Capital Employed

1.94

EV to Sales

3.46

PEG Ratio

Dividend Yield

ROCE (Latest)

6.53%

ROE (Latest)

5.29%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

KST

Dow Theory

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

36.8532

Mutual Funds

Held by 5 Schemes (6.7%)

FIIs

Held by 11 FIIs (0.66%)

Promoter with highest holding

Vijaykumar Nirani (17.88%)

Highest Public shareholder

Rakeshkumar Viththalbhai Patel (3.82%)

Individual Investors Holdings

13.5%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -14.20% vs 572.88% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -14.07% vs 254.43% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "603.22",
          "val2": "703.02",
          "chgp": "-14.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "130.98",
          "val2": "129.05",
          "chgp": "1.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "42.94",
          "val2": "39.65",
          "chgp": "8.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "56.73",
          "val2": "66.02",
          "chgp": "-14.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.71%",
          "val2": "18.36%",
          "chgp": "3.35%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398.41",
          "val2": "573.53",
          "chgp": "-30.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "23.10",
          "val2": "27.23",
          "chgp": "-15.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "75.26",
          "val2": "67.15",
          "chgp": "12.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-42.72",
          "val2": "-41.99",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.80%",
          "val2": "4.75%",
          "chgp": "1.05%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,101.43",
          "val2": "980.84",
          "chgp": "12.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "152.15",
          "val2": "146.27",
          "chgp": "4.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "114.91",
          "val2": "102.57",
          "chgp": "12.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "23.30",
          "val2": "30.39",
          "chgp": "-23.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.81%",
          "val2": "14.91%",
          "chgp": "-1.10%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -9.33% vs 53.68% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -43.09% vs 342.06% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,704.65",
          "val2": "1,880.12",
          "chgp": "-9.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "283.13",
          "val2": "297.20",
          "chgp": "-4.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "157.85",
          "val2": "141.04",
          "chgp": "11.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "80.03",
          "val2": "140.62",
          "chgp": "-43.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.61%",
          "val2": "15.81%",
          "chgp": "0.80%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

603.22

703.02

-14.20%

Operating Profit (PBDIT) excl Other Income

130.98

129.05

1.50%

Interest

42.94

39.65

8.30%

Exceptional Items

0.00

Standalone Net Profit

56.73

66.02

-14.07%

Operating Profit Margin (Excl OI)

21.71%

18.36%

3.35%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -14.20% vs 572.88% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -14.07% vs 254.43% in Dec 2025

All Quarterly Results

Half Yearly Results Snapshot (Standalone) - Sep'25

Sep'25

Sep'24

Change(%)

Net Sales

398.41

573.53

-30.53%

Operating Profit (PBDIT) excl Other Income

23.10

27.23

-15.17%

Interest

75.26

67.15

12.08%

Exceptional Items

0.00

Standalone Net Profit

-42.72

-41.99

-1.74%

Operating Profit Margin (Excl OI)

5.80%

4.75%

1.05%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Half Yearly Results

Nine Monthly Results Snapshot (Standalone) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

1,101.43

980.84

12.29%

Operating Profit (PBDIT) excl Other Income

152.15

146.27

4.02%

Interest

114.91

102.57

12.03%

Exceptional Items

0.00

Standalone Net Profit

23.30

30.39

-23.33%

Operating Profit Margin (Excl OI)

13.81%

14.91%

-1.10%

Values in Rs Cr.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Nine Monthly Results

Annual Results Snapshot (Standalone) - Mar'26

Mar'26

Mar'25

Change(%)

Net Sales

1,704.65

1,880.12

-9.33%

Operating Profit (PBDIT) excl Other Income

283.13

297.20

-4.73%

Interest

157.85

141.04

11.92%

Exceptional Items

0.00

Standalone Net Profit

80.03

140.62

-43.09%

Operating Profit Margin (Excl OI)

16.61%

15.81%

0.80%

Values in Rs Cr.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2026 is -9.33% vs 53.68% in Mar 2025

Standalone Net Profit

YoY Growth in year ended Mar 2026 is -43.09% vs 342.06% in Mar 2025

All Annual Results

Company CV

About TruAlt Bioenergy Ltd

TruAlt Bioenergy Ltd

Small Cap

Commodity Chemicals

No Details Available.

Company Coordinates

No Company Details Available